Tender Intelligence
nhs contracts expiring in 2026
Awarded contracts 12 to 36 months old, modelled as renewal and expiry signals for proactive pipeline planning.
Market context
This expiring-contract intelligence page maps awarded UK procurement notices to likely renewal timing for NHS contracts linked to 2026. Instead of waiting for fresh tenders to appear, commercial teams can monitor where current contracts are most likely to re-enter the market. The dataset below keeps the source notice context visible so you can validate buyer behaviour, procurement category and value profile before committing pursuit effort. This matters because renewal-led opportunities often move quickly once re-procurement starts, and teams that position early usually gain a stronger advantage. Use this view to identify where account planning should start now, not after notice publication. Current sample size: 2 records.
Contract table
| Contract title | Buyer | Supplier | Value | Date |
|---|---|---|---|---|
| NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets | NHS England | Not disclosed in public notice | Not disclosed | 29 Jul 2026 |
| NHS National Framework for Aripiprazole prolonged release injection | NHS England | Not disclosed in public notice | Not disclosed | 29 Jul 2026 |
Market signal snapshot
Why this page is distinct
- Scope fingerprint: NHS contracts linked to 2026.
- Entity mix: 1 buyers, 1 suppliers, 1 categories.
- Notice date span: 29 Jul 2026 to 29 Jul 2026.
- Expiry modelling focus year: 2026 with supplier disclosure at 0%.
Data-driven insights
We are tracking 2 contracts linked to likely expiry windows, representing £0 in published value and an average contract size of £0. The strongest supplier presence appears around: Not disclosed in public notice (2). The most active buyers in this expiry-led sample are: NHS England (2). Activity across the latest reporting window indicates where renewal pipeline is clustering. When expiry signals and buyer repetition align, those accounts should move to priority monitoring because procurement teams may re-open similar requirements. Where supplier concentration is high, displacement planning and relationship mapping should start earlier. This converts historical award data into forward-looking commercial actions instead of retrospective reporting.
What this means for your bid strategy
For teams targeting NHS contracts linked to 2026, the immediate opportunity is renewal timing. Prioritise buyers that appear repeatedly in this expiry window and align account outreach before re-procurement begins. Competition is concentrated around repeat winners, so incumbent tracking is essential. Where disclosure is limited, use adjacent awards and known frameworks to map likely competitor positions. The execution focus should be early qualification and proactive relationship-building so pipeline is shaped before formal notice release.
Data coverage note
Supplier disclosure coverage is currently 0% in this slice. Use buyer, value and date patterns as primary signals, and treat supplier analysis as directional where disclosure is limited.
See upcoming renewals and competitors
Move from reactive tender search to proactive pipeline qualification with earlier signals.